🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
Phase 2 open label, randomized, active controlled, dose-ranging trial in ad...
Status
Recruiting
Location
Sierra Eye Associates
Start Date
2025-03-18
Trial ID
NCT06942520
Treatments Being Tested
Main Study (CACZ885M2301): The purpose of the pivotal phase of this trial w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04-11
Trial ID
NCT01327846
Treatments Being Tested
This study evaluates the efficacy and safety of Rheosorbilact®, solution fo...
Status
Completed
Location
"Unimedi Adjara" LLC
Start Date
2018-01-10
Trial ID
NCT03771170
Treatments Being Tested
Serotoninergic activity in brain structures involved in food control and av...
Status
Terminated
Location
CHU de Saint-Etienne
Start Date
2021-12-10
Trial ID
NCT05155280
Treatments Being Tested
Parkinson's disease (PD) is a neurological condition, which affects the bra...
Status
Completed
Location
University of Alabama at Birmingham - Main /ID# 216595
Start Date
2020-10-19
Trial ID
NCT04380142
Treatments Being Tested
Patients with Common variable immunodeficiency (CVID) have various forms of...
Status
Completed
Location
Oslo University Hospital
Start Date
2013-10
Trial ID
NCT01946906
Treatments Being Tested
The purpose of this randomized study is to determine the safety and efficac...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2021-09-03
Trial ID
NCT04486833
Treatments Being Tested
The purpose of this study is to find out if SU011248 works and if it is saf...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2008-04
Trial ID
NCT00578526
The main purpose of this study is to compare the effectiveness of Human Reg...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-02
Trial ID
NCT01774968
Treatments Being Tested